Compare INFU & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | CBUS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.1M | 208.7M |
| IPO Year | 2005 | 2017 |
| Metric | INFU | CBUS |
|---|---|---|
| Price | $9.28 | $1.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $15.00 | $9.00 |
| AVG Volume (30 Days) | 96.1K | ★ 647.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | 74.33 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | $3,639,000.00 |
| Revenue This Year | $2.89 | $126.00 |
| Revenue Next Year | $7.66 | $110.01 |
| P/E Ratio | $30.00 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $4.61 | $1.09 |
| 52 Week High | $11.04 | $4.19 |
| Indicator | INFU | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 36.26 |
| Support Level | $8.52 | $1.31 |
| Resistance Level | $9.89 | $2.48 |
| Average True Range (ATR) | 0.40 | 0.32 |
| MACD | -0.09 | -0.16 |
| Stochastic Oscillator | 40.52 | 13.62 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.